Paraneoplastic syndrome: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 11: Line 11:
==Classification==
==Classification==
* Paraneoplastic syndromes may be [[Classification|classified]] into 4 main categories:
* Paraneoplastic syndromes may be [[Classification|classified]] into 4 main categories:
**[[Endocrine|Endocrine metabolic]] [[Syndrome|syndromes]]:<ref>{{MeshName|Paraneoplastic+endocrine+syndromes}}</ref><ref name="pmid15673803">{{cite journal |vauthors=Stewart AF |title=Clinical practice. Hypercalcemia associated with cancer |journal=N. Engl. J. Med. |volume=352 |issue=4 |pages=373–9 |date=January 2005 |pmid=15673803 |doi=10.1056/NEJMcp042806 |url=}}</ref><ref name="pmid16337807">{{cite journal |vauthors=Spinazzé S, Schrijvers D |title=Metabolic emergencies |journal=Crit. Rev. Oncol. Hematol. |volume=58 |issue=1 |pages=79–89 |date=April 2006 |pmid=16337807 |doi=10.1016/j.critrevonc.2005.04.004 |url=}}</ref>
**[[Endocrine|Endocrine metabolic]] [[Syndrome|syndromes]]:
***[[Hypercalcemia]] in [[breast cancer]] and [[lung cancer]] (typically [[Squamous cell carcinoma|squamous cell]]) due to the production of [[Parathyroid hormone-related protein|PTHrP]] ([[Parathyroid hormone]]-related [[protein]])
***[[Hypercalcemia]] in [[breast cancer]] and [[lung cancer]] (typically [[Squamous cell carcinoma|squamous cell]]) due to the production of [[Parathyroid hormone-related protein|PTHrP]] ([[Parathyroid hormone]]-related [[protein]])
****Seen in [[multiple myeloma]], [[renal cell carcinoma]], [[ovarian cancer]], [[endometrial cancer]], and [[lymphoma]]
****Seen in [[multiple myeloma]], [[renal cell carcinoma]], [[ovarian cancer]], [[endometrial cancer]], and [[lymphoma]]
***[[Syndrome of inappropriate antidiuretic hormone|SIADH]]<ref name="pmid17701059">{{cite journal |vauthors=Raftopoulos H |title=Diagnosis and management of hyponatremia in cancer patients |journal=Support Care Cancer |volume=15 |issue=12 |pages=1341–7 |date=December 2007 |pmid=17701059 |doi=10.1007/s00520-007-0309-9 |url=}}</ref><ref name="pmid17507705">{{cite journal |vauthors=Ellison DH, Berl T |title=Clinical practice. The syndrome of inappropriate antidiuresis |journal=N. Engl. J. Med. |volume=356 |issue=20 |pages=2064–72 |date=May 2007 |pmid=17507705 |doi=10.1056/NEJMcp066837 |url=}}</ref>
***[[Syndrome of inappropriate antidiuretic hormone|SIADH]]
****Associated [[Cancer|cancers]]: [[small cell lung cancer]], [[mesothelioma]], [[breast]], [[prostate]], [[adrenal]], [[urethral]], [[thymoma]], [[lymphoma]], GI, CNS, and [[Ewing sarcoma]]
****Associated [[Cancer|cancers]]: [[small cell lung cancer]], [[mesothelioma]], [[breast]], [[prostate]], [[adrenal]], [[urethral]], [[thymoma]], [[lymphoma]], GI, CNS, and [[Ewing sarcoma]]
***[[Ectopic]] [[ACTH]] [[secretion]] associated with [[Small cell lung cancer|small-cell lung cancer]], [[carcinoid tumor]], [[thymoma]] and other [[Cancer|cancers]]
***[[Ectopic]] [[ACTH]] [[secretion]] associated with [[Small cell lung cancer|small-cell lung cancer]], [[carcinoid tumor]], [[thymoma]] and other [[Cancer|cancers]]
***[[Tumor induced osteomalacia]]
***[[Tumor induced osteomalacia]]
***[[Hypoglycemia]]<ref name="pmid9876347">{{cite journal |vauthors=Teale JD, Marks V |title=Glucocorticoid therapy suppresses abnormal secretion of big IGF-II by non-islet cell tumours inducing hypoglycaemia (NICTH) |journal=Clin. Endocrinol. (Oxf) |volume=49 |issue=4 |pages=491–8 |date=October 1998 |pmid=9876347 |doi= |url=}}</ref>
***[[Hypoglycemia]]
****Associated [[Cancer|cancers]]: [[Gastrointestinal tract|GI]], [[mesothelioma]], [[lung]], and [[sarcomas]]
****Associated [[Cancer|cancers]]: [[Gastrointestinal tract|GI]], [[mesothelioma]], [[lung]], and [[sarcomas]]
**[[Mucocutaneous|Musculocutaneous]] paraneoplastic syndromes <ref name="pmid9208889">{{cite journal |author=Cohen PR, Kurzrock R |title=Mucocutaneous paraneoplastic syndromes |journal=Semin. Oncol. |volume=24 |issue=3 |pages=334–59 |year=1997 |pmid=9208889 |doi=}}</ref>
**[[Mucocutaneous|Musculocutaneous]] paraneoplastic syndromes  
***[[Dermatomyositis]] (25-50% of adult patients have an underlying [[malignancy]])
***[[Dermatomyositis]] (25-50% of adult patients have an underlying [[malignancy]])
***[[Leser-Trelat sign|Leser-Trélat sign]], a sudden onset of many [[Pigmented lesions|pigmented]] [[skin]] lesions
***[[Leser-Trelat sign|Leser-Trélat sign]], a sudden onset of many [[Pigmented lesions|pigmented]] [[skin]] lesions
Line 27: Line 27:
***[[Sweet's syndrome]]
***[[Sweet's syndrome]]
***[[Pyoderma gangrenosum]]
***[[Pyoderma gangrenosum]]
**[[Neurological]] paraneoplastic syndromes: <ref>{{MeshName|Nervous+system+paraneoplastic+syndromes}}</ref><ref name="pmid19620862">{{cite journal |vauthors=Didelot A, Honnorat J |title=Update on paraneoplastic neurological syndromes |journal=Curr Opin Oncol |volume=21 |issue=6 |pages=566–72 |date=November 2009 |pmid=19620862 |doi=10.1097/CCO.0b013e3283306647 |url=}}</ref>
**[[Neurological]] paraneoplastic syndromes:  
***[[Paraneoplastic cerebellar degeneration]] associated with [[lung]], [[ovarian]], [[breast]], [[lymphatic]], and other cancers
***[[Paraneoplastic cerebellar degeneration]] associated with [[lung]], [[ovarian]], [[breast]], [[lymphatic]], and other cancers
***[[Encephalomyelitis]] ([[inflammation]] of the [[brain]] and [[spinal cord]])
***[[Encephalomyelitis]] ([[inflammation]] of the [[brain]] and [[spinal cord]])
Line 33: Line 33:
***[[Encephalitis|Brainstem encephalitis]]
***[[Encephalitis|Brainstem encephalitis]]
***[[Opsoclonus]] (involving eye movement)
***[[Opsoclonus]] (involving eye movement)
***[[Encephalitis]] triggered by a [[teratoma]]<ref name="pmid17262855">{{cite journal |author=Dalmau J, Tüzün E, Wu HY, ''et al'' |title=Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma |journal=Ann. Neurol. |volume=61 |issue=1 |pages=25–36 |year=2007 |month=January |pmid=17262855 |pmc=2430743 |doi=10.1002/ana.21050 |url=}}</ref>
***[[Encephalitis]] triggered by a [[teratoma]]
***[[Polymyositis]]
***[[Polymyositis]]
***[[Lambert-Eaton myasthenic syndrome]] ([[LEMS]]) in [[Small cell lung cancer|small-cell lung cancer]]
***[[Lambert-Eaton myasthenic syndrome]] ([[LEMS]]) in [[Small cell lung cancer|small-cell lung cancer]]
Line 39: Line 39:
***Subacute (peripheral) [[sensory neuropathy]]
***Subacute (peripheral) [[sensory neuropathy]]
***[[Autonomic neuropathy]]
***[[Autonomic neuropathy]]
**[[Hematological]] paraneoplastic syndromes <ref name="pmid9208888">{{cite journal |author=Staszewski H |title=Hematological paraneoplastic syndromes |journal=Semin. Oncol. |volume=24 |issue=3 |pages=329–33 |year=1997 |pmid=9208888 |doi=}}</ref><ref name="pmid8400277">{{cite journal |vauthors=Blay JY, Favrot M, Rossi JF, Wijdenes J |title=Role of interleukin-6 in paraneoplastic thrombocytosis |journal=Blood |volume=82 |issue=7 |pages=2261–2 |date=October 1993 |pmid=8400277 |doi= |url=}}</ref>
**[[Hematological]] paraneoplastic syndromes  
***[[Granulocytosis]] (increased [[granulocyte]]s) due to the production of [[Granulocyte colony-stimulating factor|G-CSF]]
***[[Granulocytosis]] (increased [[granulocyte]]s) due to the production of [[Granulocyte colony-stimulating factor|G-CSF]]
*** [[Eosinophilia]]
*** [[Eosinophilia]]
Line 48: Line 48:
==Causes==
==Causes==
===Common Causes===
===Common Causes===
* The major [[causes]] of paraneoplastic syndrome include:<ref name="pmid1591305">{{cite journal| author=Richardson GE, Johnson BE| title=Paraneoplastic syndromes in lung cancer. | journal=Curr Opin Oncol | year= 1992 | volume= 4 | issue= 2 | pages= 323-33 | pmid=1591305 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1591305  }}</ref><ref name="pmid8946620">{{cite journal| author=Gold PJ, Fefer A, Thompson JA| title=Paraneoplastic manifestations of renal cell carcinoma. | journal=Semin Urol Oncol | year= 1996 | volume= 14 | issue= 4 | pages= 216-22 | pmid=8946620 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8946620  }}</ref><ref name="pmid191296132">{{cite journal| author=Horwhat JD, Gerke H, Acosta RD, Pavey DA, Jowell PS| title=Focal or diffuse "fullness" of the pancreas on CT. Usually benign, but EUS plus/minus FNA is warranted to identify malignancy. | journal=JOP | year= 2009 | volume= 10 | issue= 1 | pages= 37-42 | pmid=19129613 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19129613  }}</ref>
* The major [[causes]] of paraneoplastic syndrome include:
**[[Small cell lung cancer]]
**[[Small cell lung cancer]]
** [[Non-small cell lung cancer]]
**[[Non-small cell lung cancer]]
** [[Myeloma]]
**[[Multiple myeloma]]
** [[Breast cancer]]
**[[Breast cancer]]
** [[Medullary thyroid cancer]]
**[[Medullary thyroid cancer]]
** [[Bronchial]] [[carcinoid]]
**[[Bronchial]] [[carcinoid]]
** [[Pancoast tumor|Pancoast's tumour]]
**[[Pancoast tumor|Pancoast's tumour]]
** [[Pancreatic cancer]]
**[[Pancreatic cancer]]
** [[Hepatocellular carcinoma]]
**[[Hepatocellular carcinoma]]
** [[Gastric tumors]]
**[[Gastric tumors]]
** [[Gastrointestinal]] [[neuroendocrine tumors]] (NETS)
**[[Gastrointestinal]] [[neuroendocrine tumors]] (NETS)
** [[Leukemias]]
**[[Leukemias]]
** [[Lymphomas]]
**[[Lymphomas]]
** [[Skin cancers]]
**[[Skin cancers]]
** [[Renal carcinoma]]
**[[Renal carcinoma]]
===Causes by Organ System===
===Causes by Organ System===
*Paraneoplastic syndromes [[causes]] may be regrouped by organ system.<ref name="pmid20810794">{{cite journal| author=Pelosof LC, Gerber DE| title=Paraneoplastic syndromes: an approach to diagnosis and treatment. | journal=Mayo Clin Proc | year= 2010 | volume= 85 | issue= 9 | pages= 838-54 | pmid=20810794 | doi=10.4065/mcp.2010.0099 | pmc=2931619 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20810794  }} </ref><ref name="pmid30876820">{{cite journal |vauthors=Henry K |title=Paraneoplastic syndromes: Definitions, classification, pathophysiology and principles of treatment |journal=Semin Diagn Pathol |volume=36 |issue=4 |pages=204–210 |date=July 2019 |pmid=30876820 |doi=10.1053/j.semdp.2019.01.002 |url=}}</ref>
*Paraneoplastic syndromes [[causes]] may be regrouped by organ system.
{| style="width:82%; height:100px" border="1"
{| style="width:82%; height:100px" border="1"
|-
|-
Line 248: Line 248:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Small cell lung cancer]]<ref name="NCCN">[http://www.nccn.org/professionals/physician_gls/f_guidelines_nojava.asp NCCN Clinical Practice Guidelines in Oncology. Small Cell Lung Cancer, version 2.2014]</ref><ref name="CarterGlisson2014">{{cite journal|last1=Carter|first1=Brett W.|last2=Glisson|first2=Bonnie S.|last3=Truong|first3=Mylene T.|last4=Erasmus|first4=Jeremy J.|title=Small Cell Lung Carcinoma: Staging, Imaging, and Treatment Considerations|journal=RadioGraphics|volume=34|issue=6|year=2014|pages=1707–1721|issn=0271-5333|doi=10.1148/rg.346140178}}</ref>'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Small cell lung cancer]]'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Cough]]
* [[Cough]]
Line 278: Line 278:
* [[Hilar|Hilar mass]]
* [[Hilar|Hilar mass]]
| style="background: #F5F5F5; padding: 5px;" | _
| style="background: #F5F5F5; padding: 5px;" | _
| style="background: #F5F5F5; padding: 5px;" |Small, round and oval cells  
| style="background: #F5F5F5; padding: 5px;" |
[[Necrotic|Necrosis]]
* Small, round and oval cells
 
* [[Necrotic|Necrosis]]
| style="background: #F5F5F5; padding: 5px;" |[[Biopsy]]
| style="background: #F5F5F5; padding: 5px;" |[[Biopsy]]
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Squamous cell carcinoma of the lung|Squamous lung cancer]]<ref name="Rosado-de-ChristensonTempleton1994">{{cite journal|last1=Rosado-de-Christenson|first1=M L|last2=Templeton|first2=P A|last3=Moran|first3=C A|title=Bronchogenic carcinoma: radiologic-pathologic correlation.|journal=RadioGraphics|volume=14|issue=2|year=1994|pages=429–446|issn=0271-5333|doi=10.1148/radiographics.14.2.8190965}}</ref>'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Squamous cell carcinoma of the lung|Squamous lung cancer]]'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Asymptomatic]]  at first
* [[Asymptomatic]]  at first
Line 321: Line 323:
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Hepatocellular carcinoma]]<ref name="ReynoldsFurlan2015">{{cite journal|last1=Reynolds|first1=Arich R.|last2=Furlan|first2=Alessandro|last3=Fetzer|first3=David T.|last4=Sasatomi|first4=Eizaburo|last5=Borhani|first5=Amir A.|last6=Heller|first6=Matthew T.|last7=Tublin|first7=Mitchell E.|title=Infiltrative Hepatocellular Carcinoma: What Radiologists Need to Know|journal=RadioGraphics|volume=35|issue=2|year=2015|pages=371–386|issn=0271-5333|doi=10.1148/rg.352140114}}</ref><ref name="FloresLang2011">{{cite journal|last1=Flores|first1=Yvonne N.|last2=Lang|first2=Cathy M.|last3=Salmerón|first3=Jorge|last4=Bastani|first4=Roshan|title=Risk Factors for Liver Disease and Associated Knowledge and Practices Among Mexican Adults in the US and Mexico|journal=Journal of Community Health|volume=37|issue=2|year=2011|pages=403–411|issn=0094-5145|doi=10.1007/s10900-011-9457-4}}</ref>'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Hepatocellular carcinoma]]'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Asymptomatic]] at first
* [[Asymptomatic]] at first
Line 346: Line 348:
* ↑  [[Alpha fetoprotein]]
* ↑  [[Alpha fetoprotein]]
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |
*[[Ultrasonography|U/S]] : Small hypoechoic lesion
* Irregular border with [[fibrosis]], and [[calcification]]
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |
* [[Ultrasonography|U/S]] : Small hypoechoic lesion
* Irregular border with [[fibrosis]], and [[calcification]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Tumor cell|Polygonal tumor cells]]
* [[Tumor cell|Polygonal tumor cells]]
Line 375: Line 377:
!Additional findings
!Additional findings
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Breast cancer]]<ref name="Mišković2016">{{cite journal|last1=Mišković|first1=Josip|title=DIAGNOSTIC VALUE OF FINE NEEDLE ASPIRATION CYTOLOGY FOR BREAST TUMORS|journal=ACTA CLINICA CROATICA|year=2016|pages=625–628|issn=03539466|doi=10.20471/acc.2016.55.04.13}}</ref><ref name="pmid29117654">{{cite journal| author=Mišković J, Zorić A, Radić Mišković H, Šoljić V| title=Diagnostic Value of Fine Needle Aspiration Cytology for Breast Tumors | journal=Acta Clin Croat | year= 2016 | volume= 55 | issue= 4 | pages= 625-628 | pmid=29117654 | doi=10.20471/acc.2016.55.04.13 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29117654  }}</ref><ref name="pmid8004594">{{cite journal| author=McKenna RJ| title=The abnormal mammogram radiographic findings, diagnostic options, pathology, and stage of cancer diagnosis. | journal=Cancer | year= 1994 | volume= 74 | issue= 1 Suppl | pages= 244-55 | pmid=8004594 | doi=10.1002/cncr.2820741308 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8004594  }}</ref>'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Breast cancer]]'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Lump]] in the [[breast]]
* [[Lump]] in the [[breast]]
Line 408: Line 410:
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Renal cell carcinoma|Renal cancer]]<ref name="CairnsSrivastava2011">{{cite journal|last1=Cairns|first1=Paul|last2=Srivastava|first2=Sudhir|last3=Grizzle|first3=William E.|title=Renal cell carcinoma|journal=Cancer Biomarkers|volume=9|issue=1-6|year=2011|pages=461–473|issn=18758592|doi=10.3233/CBM-2011-0176}}</ref><ref name="pmid7769125">{{cite journal| author=de la Mata J, Uy HL, Guise TA, Story B, Boyce BF, Mundy GR et al.| title=Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo. | journal=J Clin Invest | year= 1995 | volume= 95 | issue= 6 | pages= 2846-52 | pmid=7769125 | doi=10.1172/JCI117990 | pmc=295971 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7769125  }}</ref><ref name="pmid3306861">{{cite journal| author=Laski ME, Vugrin D| title=Paraneoplastic syndromes in hypernephroma. | journal=Semin Nephrol | year= 1987 | volume= 7 | issue= 2 | pages= 123-30 | pmid=3306861 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3306861  }}</ref><ref name="pmid20479778">{{cite journal| author=Leveridge MJ, Bostrom PJ, Koulouris G, Finelli A, Lawrentschuk N| title=Imaging renal cell carcinoma with ultrasonography, CT and MRI. | journal=Nat Rev Urol | year= 2010 | volume= 7 | issue= 6 | pages= 311-25 | pmid=20479778 | doi=10.1038/nrurol.2010.63 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20479778  }}</ref>'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Renal cell carcinoma|Renal cancer]]'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Hematuria]]
*[[Hematuria|Dark urine]]
* [[Flank pain]]
* [[Flank pain]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 436: Line 438:
* ↑ [[LDH]]
* ↑ [[LDH]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* ↑ [[creatinine]]
* ↑ Creatinine
* ↑ [[cancer cells]] in [[Urine|urine cytology]]
* Cancer cells in [[Urine|urine cytology]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Abdominal]] CT scan:  
* [[Abdominal]] CT scan:  
** Thickened irregular walls
** Thickened irregular walls
** [[Neoplastic|neoplastic mass]]
** Neoplastic mass
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
Line 450: Line 452:
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Pancreatic cancer]]<ref name="pmid19129613">{{cite journal| author=Horwhat JD, Gerke H, Acosta RD, Pavey DA, Jowell PS| title=Focal or diffuse "fullness" of the pancreas on CT. Usually benign, but EUS plus/minus FNA is warranted to identify malignancy. | journal=JOP | year= 2009 | volume= 10 | issue= 1 | pages= 37-42 | pmid=19129613 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19129613  }}</ref><ref name="pmid15960930">{{cite journal| author=Porta M, Fabregat X, Malats N, Guarner L, Carrato A, de Miguel A et al.| title=Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage. | journal=Clin Transl Oncol | year= 2005 | volume= 7 | issue= 5 | pages= 189-97 | pmid=15960930 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15960930  }}</ref><ref name="HollyChaliha2004">{{cite journal|last1=Holly|first1=Elizabeth A.|last2=Chaliha|first2=Indranushi|last3=Bracci|first3=Paige M.|last4=Gautam|first4=Manjushree|title=Signs and symptoms of pancreatic cancer: a population-based case-control study in the San Francisco Bay area|journal=Clinical Gastroenterology and Hepatology|volume=2|issue=6|year=2004|pages=510–517|issn=15423565|doi=10.1016/S1542-3565(04)00171-5}}</ref><ref name="pmid26495795">{{cite journal| author=Schmidt-Hansen M, Berendse S, Hamilton W| title=Symptoms of Pancreatic Cancer in Primary Care: A Systematic Review. | journal=Pancreas | year= 2016 | volume= 45 | issue= 6 | pages= 814-8 | pmid=26495795 | doi=10.1097/MPA.0000000000000527 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26495795  }}</ref>'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Pancreatic cancer]]'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Epigastric]] [[pain]]
* [[Epigastric]] [[pain]]
Line 494: Line 496:
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Gastric cancer]]<ref name="pmid23667204">{{cite journal| author=Ajani JA, Bentrem DJ, Besh S, D'Amico TA, Das P, Denlinger C et al.| title=Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. | journal=J Natl Compr Canc Netw | year= 2013 | volume= 11 | issue= 5 | pages= 531-46 | pmid=23667204 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23667204  }}</ref><ref name="pmid8239772">{{cite journal| author=Wanebo HJ, Kennedy BJ, Chmiel J, Steele G, Winchester D, Osteen R| title=Cancer of the stomach. A patient care study by the American College of Surgeons. | journal=Ann Surg | year= 1993 | volume= 218 | issue= 5 | pages= 583-92 | pmid=8239772 | doi=10.1097/00000658-199321850-00002 | pmc=1243028 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8239772  }}</ref><ref name="pmid3357941">{{cite journal| author=Sussman SK, Halvorsen RA, Illescas FF, Cohan RH, Saeed M, Silverman PM et al.| title=Gastric adenocarcinoma: CT versus surgical staging. | journal=Radiology | year= 1988 | volume= 167 | issue= 2 | pages= 335-40 | pmid=3357941 | doi=10.1148/radiology.167.2.3357941 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3357941  }}</ref><ref name="pmid7859977">{{cite journal| author=Karita M, Tada M| title=Endoscopic and histologic diagnosis of submucosal tumors of the gastrointestinal tract using combined strip biopsy and bite biopsy. | journal=Gastrointest Endosc | year= 1994 | volume= 40 | issue= 6 | pages= 749-53 | pmid=7859977 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7859977  }}</ref>'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Gastric cancer]]'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* History of [[gastric ulcer]]  
* History of [[gastric ulcer]]  
Line 523: Line 525:
** Loss of [[Rugal folds|rugal fold]]
** Loss of [[Rugal folds|rugal fold]]
** [[Mucosal]] irregularity Ulcerative lesion
** [[Mucosal]] irregularity Ulcerative lesion
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Endoscopy]]: [[Ulcer]]
* [[Endoscopy]]: [[Ulcer]]
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Irregular [[tubular]] structure
* Irregular [[tubular]] structure
Line 540: Line 542:
* [[Acanthosis nigricans]]
* [[Acanthosis nigricans]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Lymphoma]]<ref name="pmid15245605">{{cite journal| author=Hagler KT, Lynch JW| title=Paraneoplastic manifestations of lymphoma. | journal=Clin Lymphoma | year= 2004 | volume= 5 | issue= 1 | pages= 29-36 | pmid=15245605 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15245605  }}</ref><ref name="pmid21339498">{{cite journal| author=Briani C, Vitaliani R, Grisold W, Honnorat J, Graus F, Antoine JC et al.| title=Spectrum of paraneoplastic disease associated with lymphoma. | journal=Neurology | year= 2011 | volume= 76 | issue= 8 | pages= 705-10 | pmid=21339498 | doi=10.1212/WNL.0b013e31820d62eb | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21339498  }}</ref>'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Lymphoma]]'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Weight loss]]
* [[Weight loss]]
Line 569: Line 571:
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |_
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Ovarian cancer]]<ref name="pmid22217630">{{cite journal| author=Hippisley-Cox J, Coupland C| title=Identifying women with suspected ovarian cancer in primary care: derivation and validation of algorithm. | journal=BMJ | year= 2011 | volume= 344 | issue=  | pages= d8009 | pmid=22217630 | doi=10.1136/bmj.d8009 | pmc=3251328 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22217630  }}</ref><ref name="pmid22405464">{{cite journal| author=Li J, Fadare O, Xiang L, Kong B, Zheng W| title=Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis. | journal=J Hematol Oncol | year= 2012 | volume= 5 | issue=  | pages= 8 | pmid=22405464 | doi=10.1186/1756-8722-5-8 | pmc=3328281 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22405464  }}</ref>'''
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''[[Ovarian cancer]]'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Asymptomatic]] at first
* [[Asymptomatic]] at first
Line 600: Line 602:
* [[Psammoma body|Psammoma bodies]]
* [[Psammoma body|Psammoma bodies]]
* [[Necrosis]]
* [[Necrosis]]
| style="background: #F5F5F5; padding: 5px;" |_
| style="background: #F5F5F5; padding: 5px;" |
* [[Biopsy]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Trousseau's syndrome|Trousseau]] [[syndrome]]
* [[Trousseau's syndrome|Trousseau]] [[syndrome]]
Line 610: Line 613:
[[Category:Mature chapter]]
[[Category:Mature chapter]]
[[Category:Needs content]]
[[Category:Needs content]]
<references />

Revision as of 16:08, 11 October 2019

PCFor patient information, click here

Paraneoplastic syndrome Microchapters

Patient Information

Overview

Classification

Endocrine
Musculocutaneous
Neurological
Hematological
Others

Causes

Differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Gertrude Djouka, M.D.[2]

Synonyms and keywords: Paraneoplastic syndrome

Overview

Paraneoplastic syndromes are a rare type of disease that is caused by abnormal immune systems resulting from cancerous cells. Paraneoplastic syndromes are disorders due to the release of hormones, or peptides that cause immune cross-reactivity between cancerous cells and normal tissues. Sometimes the symptoms of paraneoplastic syndromes show even before the diagnosis of a malignancy. There is no screening for paraneoplastic syndromes. The stage and type of diagnosis of cancer determine the prognosis of a paraneoplastic syndrome. The causes are mostly related to the organ affected. The paraneoplastic syndromes are divided into four main categories such as musculocutaneous, neurological, hematological and endocrines. They are no cures for the paraneoplastic syndrome, but cancer treatment and some medications to reduce autoimmune responses are helpful.

Classification

Causes

Common Causes

Causes by Organ System

  • Paraneoplastic syndromes causes may be regrouped by organ system.
Dermatologic
Ear Nose Throat
Endocrine
Gastroenterologic
Hematologic
Musculoskeletal/Orthopedic
Neurologic
Obstetric/Gynecologic
Oncologic
Pulmonary
Renal/Electrolyte
Rheumatology/Immunology/Allergy
  • No underlying causes
Urologic
Miscellaneous

Differential diagnosis

Paraneoplastic syndromes must be differentiated from others types of cancer depending on the location and type of organs.

Diseases Clinical manifestations Para-clinical findings Gold standard Additional findings
Symptoms Physical examination
Lab Findings Imaging Histopathology
Small cell lung cancer _ _
  • Small, round and oval cells
Biopsy _
Squamous lung cancer


_ _ _ _
Hepatocellular carcinoma _ _ _ _
Diseases Symptom 1 Symptom 2 Symptom 3 Physical exam 1 Physical exam 2 Physical exam 3 Lab 1 Lab 2 Lab 3 Imaging 1 Imaging 2 Imaging 3 Histopathology Gold standard Additional findings
Breast cancer _ _ _ _ _ _
Renal cancer
  • Abdominal CT scan:
    • Thickened irregular walls
    • Neoplastic mass
_ _
  • Depends on the subtypes
_
Pancreatic cancer _
  • U/S: hypoechoic mass
_
Gastric cancer


_ _ _
Lymphoma _ _ _ _
  • Depends on the type of lymphoma
_
Ovarian cancer _ _

References